NSE filing, NSE: INDUSTOWER. Summary written from the filing by ALFA Finder's alert engine.
Indus Towers Ltd: key numbers
- Share price
- ₹387.00
- Market cap
- ₹1,02,097 Cr
- Revenue (annual)
- ₹32,493 Cr
- Net profit (annual)
- ₹7,145 Cr
- P/E (TTM)
- 14.4×Sector 38.5×
- Promoter holding
- 51.26%+0.00% QoQ
- FII holding
- 21.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indus Towers Ltd
All →Indus Towers Earnings Call Transcript: Key Takeaways
Indus Towers delivered steady operational growth driven by strong co-location additions and network expansion from a major customer.
Indus Towers Results Update
Indus Towers released its Q2 and half-year quarterly report with audited results. Headline revenue and profit figures are not visible in these pages.
Indus Towers Q2 FY27 Results: Net Profit ₹1,793 Cr, Down 2.5% YoY
Indus Towers Ltd reported revenue from operations of ₹8,516 Cr (+4.0% YoY) and net profit of ₹1,793 Cr (-2.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,793 Cr · -2.5% YoY
Indus Towers Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Indus Towers Board Meeting Date
Indus Towers announced a board meeting on October 27, 2026, to consider and approve its audited financial results for the second quarter ended September 30, 2026.
Indus Towers Other Announcement
Indus Towers Limited has been assigned an ESG Rating of 69.86 (Leader) by Niche Ninety Nine Capability and Certifications (OPC) Private Limited.
Other other announcement announcements
All →Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.
Archidply Industries Other Announcement
Archidply Industries disclosed that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad from December 1, 2026. The registered office is unchanged and shareholders should update correspondence addresses.
KEI Industries Other Announcement
Designated person Jashobant Singha Ray pledged 1,500 KEI Industries shares. After the transaction, 10,000 of his 18,000 shares are pledged, with no cash consideration disclosed.
Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.